United States · FDA National Drug Code directory

GUAIFENESIN

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 62207-839_44f3065d-0001-622b-e063-6394a90a2775
Product NDC: 62207-839
Form: TABLET, EXTENDED RELEASE
Composition / generic term: GUAIFENESIN
Labeler: Granules India Ltd
Marketing category: ANDA
Marketing start / end (source format): 20201218
Source listing expiry: 20261231

Source-listed ingredients

GUAIFENESIN — 600 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

9 BLISTER PACK in 1 CARTON (62207-839-72) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 62207-839-72

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →